Development of an immunohistochemical assay for Siglec-15
Saba Shafi(Ministry of Education of the People's Republic of China), David L. Rimm(Yale University), Niki Gavrielatou(National and Kapodistrian University of Athens), Thazin Nwe Aung(Yale University), Sol Langermann, Nalin Leelatian(Yale University), Linda N. Liu(Amplimmune (United States)), Aileen I. Fernandez(Yale University), Jon Zugazagoitia(Instituto de Salud Carlos III), Vesal Yaghoobi(Yale University), Robert Homer(Yale University), Charles T. Robbins(Yale University), Zachary Cusumano, Shuqiong Niu, He Wang(Qilu University of Technology), Ioannis Vathiotis(Yale University), Kimberley Cole(Yale University), Roy S. Herbst(Smilow Cancer Hospital)
Cited by 13
Related Papers
Lung Cancer
|New England Journal of Medicine|2008|2.4k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k